ID: ALA1630006

Max Phase: Preclinical

Molecular Formula: C13H18O3

Molecular Weight: 222.28

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCC/C=C/C(O)C#CC#C[C@@H](O)[C@H](C)O

Standard InChI:  InChI=1S/C13H18O3/c1-3-4-5-8-12(15)9-6-7-10-13(16)11(2)14/h5,8,11-16H,3-4H2,1-2H3/b8-5+/t11-,12?,13+/m0/s1

Standard InChI Key:  REGOORXTKQVNOO-XWRSLROKSA-N

Associated Targets(non-human)

Quinone oxidoreductase 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 222.28Molecular Weight (Monoisotopic): 222.1256AlogP: 0.45#Rotatable Bonds: 4
Polar Surface Area: 60.69Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.38CX Basic pKa: CX LogP: 1.59CX LogD: 1.59
Aromatic Rings: 0Heavy Atoms: 16QED Weighted: 0.48Np Likeness Score: 2.62

References

1. Shin D, Yang JE, Lee SB, Nho CW..  (2010)  SAR studies of gymnasterkoreayne derivatives with cancer chemopreventive activities.,  20  (24): [PMID:21050753] [10.1016/j.bmcl.2010.07.066]

Source